Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	[rituximab]	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 14 💬
2	Abatacept, rituximab or tocilizumab	Abatacept	[3] D02596, D02994, D03203 💬	[4] CD80, CD86, IL6R, MS4A1 💬	[24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor	[1] 46 💬
3	Abp 798 - biosimilar to rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
4	Abp 798 biosimilar to rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
5	Administration of rituximab and methylprednisolone	Methylprednisolone	[7] D00407, D00751, D00979, D02994, D05000, D05001, D05002 💬	[2] MS4A1, NR3C1 💬	[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	[1] 51 💬
6	Alemtuzumab and rituximab	Alemtuzumab	[2] D02802, D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 60 💬
7	Alemtuzumab, rituximab	Alemtuzumab	[2] D02802, D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 63 💬
8	Anti-cd20 b cell depletion with truxima	-	-	-	-	[1] 49 💬
9	Bendamustine, rituximab	Bendamustine	[3] D02994, D07085, D07501 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 61 💬
10	Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine	Azathioprine	[12] D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬	[2] MS4A1, NR3C1 💬	[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	[1] 35 💬
11	Combined plasma exchange (pex), rituximab, and corticosteroids	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 85 💬
12	Dexamethasone and rituximab	Dexamethasone	[10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994 💬	[2] MS4A1, NR3C1 💬	[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	[1] 63 💬
13	Double-blind rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 51 💬
14	Dr. reddy’s rituximab (drl_ri) 100mg	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
15	Dr. reddy’s rituximab (drl_ri) 500mg	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
16	Eltrombopag combining rituximab	Eltrombopag	[2] D02994, D03978 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 63 💬
17	Etanercepet, rituximab, abatacept, tocilizumab, sarilumab	Abatacept	[4] D02596, D02994, D03203, D10161 💬	[4] CD80, CD86, IL6R, MS4A1 💬	[24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor	[1] 46 💬
18	Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 222 💬
19	Gp2013 - a proposed biosimilar rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
20	Idec-c2b8 (rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
21	Immunosuppressive treatment (eg, rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 64 💬
22	Individualized dose of rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 49 💬
23	Intravenous rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 66 💬
24	Mabthera (rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[4] 13, 46, 49, 53 💬
25	Mabthera or biosimilar rituximab product	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
26	Mabthera® (rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
27	Originator rituximab - rituxan ® or mabthera ®	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
28	Prednisone, low dose rituximab	Prednisone	[2] D00473, D02994 💬	[2] MS4A1, NR3C1 💬	[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction	[1] 61 💬
29	Rhtpo in combination with rituximab	Recombinant Human Thrombopoietin	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 63 💬
30	Rituxan (inn: rituximab), brand name in the united states	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
31	Rituxan (inn: rituximab), brand name in the us	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
32	Rituxan (rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 49 💬
33	Rituxan® (rituximab)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
34	Rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
35	Rituximab (anti-cd20)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 53 💬
36	Rituximab (arm a)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[2] 43, 44 💬
37	Rituximab (arm b)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[2] 43, 44 💬
38	Rituximab (eu)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
39	Rituximab (genetical recombination)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 14 💬
40	Rituximab (mabthera® or rituxan®).	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[2] 35, 61 💬
41	Rituximab (mabthera®)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 61 💬
42	Rituximab (rituxan)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 11 💬
43	Rituximab (rtx) and azathioprine (aza)	Azathioprine	[3] D00238, D02994, D03033 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 65 💬
44	Rituximab (us)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
45	Rituximab - mabthera	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
46	Rituximab 1g iv	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 162 💬
47	Rituximab [mabthera/rituxan]	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[2] 46, 63 💬
48	Rituximab [mabthera]	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
49	Rituximab and cyclophosphamide iv	Cyclophosphamide	[3] D00287, D02994, D07760 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 35 💬
50	Rituximab combined with omalizumab	Omalizumab	[2] D02994, D05251 💬	[2] FCER1A, MS4A1 💬	[5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway	[1] 162 💬
51	Rituximab infusion	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[2] 13, 222 💬
52	Rituximab it	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
53	Rituximab iv	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
54	Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 13 💬
55	Rituximab mabthera	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
56	Rituximab or rituximab hyaluronidase human	Hyaluronidase	[4] D02994, D04455, D04456, D06604 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 331 💬
57	Rituximab, mabthera	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 53 💬
58	Rituximab, mtx, folic acid	Folic acid	[2] D00070, D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
59	Rituximab, observational study amon patients with active ra	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
60	Rituximab-eu+ rituximab-pfizer x 2 courses	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
61	Rituximab-pfizer	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
62	Rituximab-pfizer (pf-05280586) x 3 courses	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
63	Rituximab-us + rituximab-pfizer x 2 courses	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
64	Rituximab/ mabthera	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 271 💬
65	Sait101 (proposed rituximab biosimilar)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
66	Sait101 (rituximab biosimilar)	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 46 💬
67	Standard dose of rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 49 💬
68	The standard steroid treatment, plasma exchange and rituximab	Rituximab	[1] D02994 💬	[1] MS4A1 💬	[1] Hematopoietic cell lineage	[1] 85 💬
69	Truxima	-	-	-	-	[2] 49, 222 💬
70	Truximab	-	-	-	-	[1] 222 💬

Back to top